VWD types and laboratory test results
| VWD type . | Description . | VWF:Ag . | VWF activity∗ . | VWF activity/Ag . | FVIII:C . | Multimers . | Other tests/results . |
|---|---|---|---|---|---|---|---|
| 1 | Partial quantitative deficiency VWF | ↓ to ↓↓ | ↓ to ↓↓ | >0.7 | Normal to ↓ | Normal | N/A |
| 1C | Increased clearance of VWF | ↓ to ↓↓ | ↓ to ↓↓ | >0.7 | Normal to ↓ | Normal | DDAVP trial; increased ratio of VWFpp to VWF:Ag |
| 2A | Decreased VWF-dependent platelet adhesion with deficiency of HMWM | Normal to ↓ | ↓↓ | <0.7 | Normal to ↓ | Loss of HMWM | Abnormal VWF:CB |
| 2B | Increased affinity for platelet GPIbα | ↓ | ↓↓ | <0.7 | Normal to ↓ | Loss of HMWM | Abnormal VWF:CB; enhanced RIPA; genetic testing |
| 2M | Decreased VWF-dependent platelet adhesion with normal multimers | ↓ | ↓↓ | <0.7 | Normal to ↓ | Normal | Normal VWF:CB |
| 2N | Decreased binding affinity for FVIII | ↓ | ↓↓ | <0.7 | Normal to ↓ | Normal | Decreased VWF:FVIIIB; genetic testing |
| 3 | Virtually complete quantitative deficiency of VWF | ↓↓↓ | ↓↓↓ | N/A | ↓↓↓ | Absent | N/A |
| VWD type . | Description . | VWF:Ag . | VWF activity∗ . | VWF activity/Ag . | FVIII:C . | Multimers . | Other tests/results . |
|---|---|---|---|---|---|---|---|
| 1 | Partial quantitative deficiency VWF | ↓ to ↓↓ | ↓ to ↓↓ | >0.7 | Normal to ↓ | Normal | N/A |
| 1C | Increased clearance of VWF | ↓ to ↓↓ | ↓ to ↓↓ | >0.7 | Normal to ↓ | Normal | DDAVP trial; increased ratio of VWFpp to VWF:Ag |
| 2A | Decreased VWF-dependent platelet adhesion with deficiency of HMWM | Normal to ↓ | ↓↓ | <0.7 | Normal to ↓ | Loss of HMWM | Abnormal VWF:CB |
| 2B | Increased affinity for platelet GPIbα | ↓ | ↓↓ | <0.7 | Normal to ↓ | Loss of HMWM | Abnormal VWF:CB; enhanced RIPA; genetic testing |
| 2M | Decreased VWF-dependent platelet adhesion with normal multimers | ↓ | ↓↓ | <0.7 | Normal to ↓ | Normal | Normal VWF:CB |
| 2N | Decreased binding affinity for FVIII | ↓ | ↓↓ | <0.7 | Normal to ↓ | Normal | Decreased VWF:FVIIIB; genetic testing |
| 3 | Virtually complete quantitative deficiency of VWF | ↓↓↓ | ↓↓↓ | N/A | ↓↓↓ | Absent | N/A |
↓, slightly reduced; ↓↓, moderately reduced; ↓↓↓, significantly reduced; DDAVP, desmopressin (1-deamino-8-D-arginine vasopressin); N/A, not applicable.
VWF:GPIbM (GPIb binding assay for VWF using recombinant mutated GPIb, no ristocetin) or VWF:GPIbR (GPIb binding assay for VWF using recombinant GPIb and ristocetin).